Inhibitory Potential of Boscalid and Abamectin Towards Acetylcholinesterase and Butyrylcholinesterase: Computational and In Vitro Studies
International Journal of Molecular Sciences · 21.03.2025 · 26 (7) · 2865
DOI: 10.3390/ijms26072865 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.03.2025. Verfasst von Biljana Arsić und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, 18000 Niš, Serbia. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Ivermectin, Cholinesterase Inhibitors, Acetylcholinesterase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science and Technological Development of the Republic of Serbia, Ministry of Science, Technological Development and Innovations of the Republic of Serbia, Slovenian Research and innovation Agency.
Abstract (Originalsprache)
The growing demand for agricultural products has led to the misuse of pesticides, resulting in the use of higher concentrations of these substances. This has led to an increase in toxicity imposed on other beneficial organisms and to the bioaccumulation of toxic pesticide concentrations in the bodies of both pests and non-target organisms, as well as in their end users, including humans. In this study, the neurotoxic potential of the commonly used pesticides abamectin (an insecticide) and boscalid (a fungicide) was evaluated. Both in vitro and in silico studies showed that human butyrylcholinesterase is not a target for abamectins B1A and B1B. Boscalid showed a modest Glide score (−28.8 kJ/mol) and a considerably higher IC50 (308.8 µM) against human butyrylcholinesterase than the approved inhibitor (2-((1-(benzenesulfonyl)-1H-indol-4-yl)oxy)ethyl)(benzyl)amine (IC50 = 0.473 µM). However, due to its non-mutagenicity and low toxicity, structural analogues of boscalid might be considered as candidates for the symptomatic treatment of Alzheimer’s disease. Molecular dynamics simulations over 100 ns confirmed the stability of boscalid within the active site of butyrylcholinesterase, where it maintained key interactions with catalytic residues such as Trp82 and His438. These findings highlight its potential as a starting point for structure-based drug design strategies aimed at optimizing cholinesterase inhibitors with improved pharmacokinetic properties. According to absorption, distribution, metabolism, elimination, and toxicity studies, boscalid is orally active, which cannot be attributed to abamectins B1A and B1B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, 18000 Niš, Serbia.
- Department of Chemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
- Institute of Preclinical Sciences, Veterinary Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Department of Biology, Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Department for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Biljana Arsić, Stefan Petrović, Budimir S Ilić, Milka Vrecl, Tomaž Trobec, Kristina Sepčić, Robert Frangež, Sanja M Glišić, Jelena S Milićević
Förderung
- Ministry of Education, Science and Technological Development of the Republic of Serbia
- Ministry of Science, Technological Development and Innovations of the Republic of Serbia
- Slovenian Research and innovation Agency
- Ministry of Education, Science and Technological Development of the Republic of Serbia between Slovenia and the Republic of Serbia
Zitieren
APA
Arsić, B., Petrović, S., Ilić, B. S., Vrecl, M., Trobec, T., Sepčić, K., Frangež, R., Glišić, S. M., & Milićević, J. S. (2025). Inhibitory Potential of Boscalid and Abamectin Towards Acetylcholinesterase and Butyrylcholinesterase: Computational and In Vitro Studies. International Journal of Molecular Sciences, 26(7), 2865. https://doi.org/10.3390/ijms26072865
Vancouver
Arsić B, Petrović S, Ilić BS, Vrecl M, Trobec T, Sepčić K, et al. Inhibitory Potential of Boscalid and Abamectin Towards Acetylcholinesterase and Butyrylcholinesterase: Computational and In Vitro Studies. International Journal of Molecular Sciences. 2025;26(7):2865. doi:10.3390/ijms26072865
BibTeX
@article{Arsi2025,
author = {Arsić, Biljana and Petrović, Stefan and Ilić, Budimir S and Vrecl, Milka and Trobec, Tomaž and Sepčić, Kristina and Frangež, Robert and Glišić, Sanja M and Milićević, Jelena S},
title = {Inhibitory Potential of Boscalid and Abamectin Towards Acetylcholinesterase and Butyrylcholinesterase: Computational and In Vitro Studies},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {7},
pages = {2865},
doi = {10.3390/ijms26072865}
}
EUVIMED